Skip to main content
Erschienen in: European Archives of Psychiatry and Clinical Neuroscience 8/2012

Open Access 01.12.2012 | Original Paper

Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning

verfasst von: David Zilles, Jobst Meyer, Thomas Schneider-Axmann, Savira Ekawardhani, Eva Gruber, Peter Falkai, Oliver Gruber

Erschienen in: European Archives of Psychiatry and Clinical Neuroscience | Ausgabe 8/2012

Abstract

Working memory deficits are found in different psychiatric populations and are most pronounced in schizophrenia. There is preliminary evidence from pharmacological studies that the verbal and visuospatial subcomponents of working memory are subject to differential neurotransmitter modulation. Here, we investigated the impact of well-known polymorphisms of the dopamine transporter gene (SLC6A3, DAT) and the catechol-O-methyl-transferase gene (COMT) as well as the serotonin transporter gene (SLC6A4, 5-HTT) on these specific working memory subcomponents in a mixed sample of patients and healthy individuals. Twenty healthy subjects and 80 patients diagnosed with schizophrenia, bipolar I disorder, or obsessive-compulsive disorder underwent genotyping for the DAT variable number of tandem repeats (VNTR), the COMT val/met-, and the 5-HTT promoter length polymorphism (5-HTTLPR) and neuropsychological testing using a battery of well-characterized, brain circuit–specific working memory tasks. DAT genotype revealed a significant and selective effect on visuospatial working memory, while there was no effect on verbal working memory functioning. 5-HTT genotype, by contrast, exerted a significant and selective effect on verbal working memory task performance. COMT genotype did not show any influence on either working memory domain. The results of the present study provide evidence for a differential impact of genetic polymorphisms of the dopaminergic and serotonergic systems on verbal and visuospatial working memory functioning. Together with prior evidence suggesting the existence of subgroups of schizophrenia patients exhibiting isolated deficits in only one working memory domain, this finding further supports the idea of endophenotypically and pathophysiologically distinct subgroups of schizophrenia with implications for personalized therapeutic approaches.

Introduction

Working memory (WM) deficits have been described in different psychiatric populations and are most prominently found in schizophrenia [21]. Therefore, WM dysfunction is supposed to represent a promising endophenotype for psychotic disorders including schizophrenia and bipolar disorder [41]. According to the endophenotype concept [24], neurocognitive functions are thought to mediate between the genetic basis of psychiatric disorders and their complex and often phase-dependent clinical phenotype. Endophenotypes are assumed to be influenced more directly and (being less complex phenotypes) by a smaller number of genes compared to the disease phenotypes. The identification of genes influencing WM functioning may prove helpful to elucidate possibly shared genetic and pathophysiological processes with an impact on both endophenotype and disease. In this context, genes that directly affect the neurotransmitter systems that are presumably involved in the pathophysiology of psychiatric disorders are especially interesting. Knowledge about their pathophysiological effects could help to generate new therapeutic approaches for treating both cognitive dysfunction and clinical symptomatology.
As a basic cognitive function, WM comprises the short-term storage (maintenance) and manipulation of a limited amount of information. It is assumed to consist of different specialized subsystems including the phonological loop for the maintenance of verbal information and the visuospatial sketchpad for the maintenance of spatial information [5]. Previous functional MRI studies have identified distinct neural networks underlying specific verbal and visuospatial WM functions in healthy individuals [26, 27, 30, 32, 33, 44] and psychiatric populations [31, 3739]. Together with complementary lesion studies [29], these data allowed to establish clear brain-behavior relationships between specific brain circuits and the verbal and visuospatial subcomponent of human WM. Behavioral deficits in patient populations can thus be attributed to specific disturbances of the underlying neurofunctional systems [28, 34, 7173]. Interestingly, a recent study provided evidence for the existence of subgroups of patients with schizophrenia who exhibit isolated deficits in only one domain of WM [72], suggesting a selective disturbance of the neural networks underlying either verbal or visuospatial WM functioning.
In accordance with the neuroanatomical dissociation of the verbal and visuospatial WM subcomponent, there is some evidence that these WM domains are subject to differential neurotransmitter modulation. As pharmacological studies in animals have of course focused on spatial WM (for review, see [18]), particularly for this domain, an association between dopamine levels and performance has been established. Spatial WM performance is assumed to depend on an optimal level of dopaminergic signaling in terms of an inverted U-shaped curve. Most pharmacological studies in humans also investigated the effects of altered dopamine levels on the visuospatial component of WM (for reviews, see [6, 20]), while data are much scarcer for the verbal domain with negative results, for instance, for the n-back WM task [43]. Other neurotransmitter systems are also involved in the modulation of cognitive processes. Regarding serotonin, there is at least some evidence for a selective modulatory effect on verbal memory functions. One study investigating healthy adults found a worsening of verbal (digits backward) and affective (pictures of facial affect) WM performance following tryptophan loading (leading to increased cortical serotonin levels), while this condition had no effect on spatial memory span [49]. In another study, tryptophan depletion (leading to reduced serotonin synthesis) resulted in impaired delayed word recall while leaving spatial WM unaffected. Tyrosine and phenylalanine depletion (predominantly leading to dopaminergic changes), by contrast, resulted in a worse performance in spatial WM but not delayed word recall [35]. The evidence outlined above thus endorses the notion that serotonergic modulation primarily affects verbal but not visuospatial cognitive processes, whereas the opposite could be true for dopaminergic neurotransmission.
Dopamine levels are substantially regulated by its reuptake via the dopamine transporter (DAT) and by enzymatic degradation by catechol-O-methyl-transferase (COMT) or monoamine oxidase A (MAOA). The activity of these clearing processes varies by the existence of different polymorphisms in the respective genes (COMT, MAOA). The COMT valine/methionine-encoding polymorphism (Val158Met) is characterized by a decreased enzyme activity for the methionine variant at body temperature [46] and consequently higher synaptic dopamine levels. With regard to the DAT gene (DAT), there is a variable number of tandem repeats (VNTR) polymorphism leading to altered gene expression. Results concerning the functional consequences of the DAT VNTR polymorphism (i.e., DAT availability as measured by SPECT) have, however, been inconsistent [68].
Associations of these polymorphisms with cognitive measures have been reported. There is some evidence for better performance of individuals homozygous for the methionine-encoding variant of COMT compared to the val/val genotype especially in the Wisconsin card sorting test (WCST) [16, 19] and also in n-back tasks [22]. However, a recent meta-analysis [7] did not confirm these effects. Another study provides evidence for better performance of healthy DAT 10/10 individuals in smooth pursuit eye movement, a construct similar to visuospatial working memory [69].
Serotonin levels are in part regulated by the serotonin transporter (5-HTT). A polymorphism in the regulatory region of the respective gene (5-HTT), the 5-HTT linked polymorphic region (5-HTTLPR), leads to altered 5-HTT expression in vitro. Higher expression was associated with the long (L) allele as compared to the short (S) allele [36]. A positron emission tomography study found 5-HTT availability in the PFC and the parietal cortex to be associated with the performance in several verbal memory tasks including digit span forward and backward [50]. However, to our knowledge, there are no publications that reported significant associations between 5-HTTLPR genotype and specific WM measures to date.
The aim of the present study was to investigate the impact of genetic polymorphisms of the dopaminergic and serotonergic system (i.e., DAT, COMT, and 5-HTT) on different verbal and visuospatial WM maintenance tasks in a mixed sample of healthy probands and patients with schizophrenia, bipolar disorder, and obsessive-compulsive disorder. According to the evidence outlined above, our hypothesis was that the DAT and COMT polymorphism would impact on visuospatial but not verbal WM, whereas the 5-HTT polymorphism should vice versa influence verbal but not visuospatial WM functioning.

Methods

Subjects

A total of 100 subjects were included in this study comprising patients with schizophrenia (n = 32), bipolar I disorder (n = 22), obsessive-compulsive disorder (n = 26), and healthy individuals (n = 20). Selection criteria for patients were diagnosis of schizophrenia, bipolar disorder, or obsessive-compulsive disorder, according to ICD-10 criteria, and age range from 18 to 65 years. Exclusion criteria were acute suicidality, involuntary treatment, current substance abuse, history of brain trauma, diseases with alterations in cerebral metabolism, uncorrected visual or auditory disability, and mental retardation. Exclusion criteria for healthy control subjects were the same as above plus the presence of any past or present psychiatric disorder. Diagnoses were established through clinical interviews by two experienced psychiatrists using symptom checklists according to ICD-10 criteria. At the time of study participation, most patients received a stable medication including typical and atypical antipsychotics, antidepressants, mood stabilizers, and low-dose benzodiazepines depending on the disorder. For further sample characteristics, see Table 1. All subjects gave written informed consent before participation. The study was approved by the local ethics committee.
Table 1
Sample characteristics
 
Healthy (n = 20)
Schizophrenia (n = 32)
Bipolar disorder (n = 22)
OCD (n = 26)
Demographic factors
Age
34.9 (12.7)
36.3 (10.2)
43.8 (12.4)
35.5 (8.8)
Years of education
14.9 (2.66)
13.5 (3.2)
14.6 (3.1)
13.7 (2.2)
Gender (m; f)
6; 14
17; 15
11; 11
11; 15
Genotype
DAT (10/10; 9-carriers)
9; 11
21; 11
14; 8
14; 12
5-HTT (L/L; other)
9; 11
11; 20 (missing: 1)
7; 15
10; 16
COMT (met/met; val/met; val/val)
4; 9; 6 (missing: 1)
6; 21; 4 (missing: 1)
6; 7; 9
6; 10; 10
Symptom scores
CGI
 
3.94 (0.93)
3.52 (1.63)
3.85 (1.08)
MADRS
 
11.78 (7.54)
6.77 (7.33)
11.2 (7.42)
PANSS positive
 
13.83 (4.65)
8.0 (1.45)
n/a
PANSS negative
 
12.9 (5.05)
9.6 (4.96)
n/a
YMRS
 
n/a
3.38 (2.96)
n/a
Y-BOCS
 
n/a
n/a
20.77 (7.69)
WM performance (accuracy in %)
Verbal rehearsal
94.4 (3.5)
82.9 (12.1)
89.1 (6.6)
91.4 (7.1)
Non-articulatory phonological maintenance
87.4 (5.6)
79.6 (10.8)
81.3 (9.9)
79.9 (8.2)
Visuospatial rehearsal
93.6 (7.0)
79.7 (15.1)
85.9 (11.4)
88.0 (11.6)
Visuospatial pattern maintenance
89.1 (8.8)
75.4 (13.8)
82.9 (9.8)
80.7 (13.1)
Given are the means (standard deviations) of demographic variables, genotype frequencies, and the psychopathology scores of the diagnostic groups
CGI Clinical Global Impression, MADRS Montgomery Asberg Depression Rating Scale, PANSS Positive and Negative Syndrome Scale, YMRS Young Mania Rating Scale, Y-BOCS Yale-Brown Obsessive Compulsive Scale

Experimental design

Testing was conducted in an experimental neuropsychological laboratory under standardized conditions using a modified Sternberg paradigm (delayed match-to-sample task) [62]. The behavioral experiment consisted of four tasks testing verbal and visuospatial WM, each under single-task conditions (i.e., active rehearsal of the sample items) as well as under dual-task conditions (i.e., articulatory or visuospatial suppression). These different task conditions were conducted in a blocked manner, and each task was repeated 50 times with a short pause after 25 trials. The order of tasks was counterbalanced across subjects within each diagnostic group.
Stimulus presentation was identical for each of the four task conditions. A 5 × 5 matrix appeared on the monitor for 2 s with four squares of the matrix randomly filled by also randomly chosen, phonologically similar letters. In the 3.2-s delay period, the empty matrix was visible together with a little star moving across the screen. Simultaneously, rhythmic 4-kHz tones were presented throughout the delay period with a repetition frequency of 3.3 Hz to set the pace of the rehearsal or counting. During this interval, subjects had to keep the letters or the spatial positions in mind using the specific strategies described below. In the response phase, a single letter was presented in the matrix for 2 s. Subjects had to decide whether the probe letter (verbal WM tasks) or its position (visuospatial WM tasks) matched one of the four target letters or positions, respectively, presented at the beginning. Together with the 2-s intertrial interval, the total length of a single trial was 9.2 s resulting in a task duration of about 8 min for each of the four tasks.
In the ‘verbal rehearsal task’, subjects were instructed to vocalize the four sample letters internally one time in the presentation period and then to rehearse them throughout the delay period. In the ‘non-articulatory phonological maintenance task’, subjects were instructed to vocalize the four sample letters one time but then to continuously count from one to four during the delay period. This articulatory suppression task has been proven to selectively interfere with verbal WM [4, 33]. In the ‘visuospatial rehearsal task’, subjects were instructed to repetitively perform overt shifts of attention to the four spatial positions, a strategy termed ‘visuospatial rehearsal mechanism’ by some authors [3]. In the ‘visuospatial pattern maintenance task’, subjects had to remember the spatial pattern built by the four sample positions while performing a visuospatial suppression task by following the moving star with their eyes. This procedure had been proven to selectively interfere with visuospatial WM [4, 33].

Genotyping

Standard PCR and genotyping were performed essentially as described earlier by our group. For DAT-specific PCR conditions, see [58]; for 5-HTTLPR, see [59]; for COMT, see [54].

Statistical analysis

All statistical analyses were performed using PASW Statistics, version 18.0.0. According to our hypothesis regarding a differential impact of dopaminergic and serotonergic neurotransmission on verbal and visuospatial WM functions, we first performed analyses of variance (ANOVAs) for each of the three genes (DAT, COMT, and 5-HTT) with genotype and diagnosis as factors. Dependent variables were visuospatial WM task performance for DAT and COMT and verbal WM task performance for 5-HTT. Given the a priori hypotheses we had for each gene, adjustment for multiple comparisons was not required for these analyses. Subsequently, multivariate analyses of variance (MANOVAs) with genotype and diagnosis as factors were performed to confirm the selectivity of genotype effects on the different WM domains. When significant main effects were present, Bonferroni-corrected post hoc comparisons were made.
With regard to the genotypes, the following groups were analyzed. For DAT, 9-repeat carriers were grouped together as it has been established by previous studies [11, 55] because of the relatively small number of 9-repeat homozygote subjects. Group comparisons were thus made for 10-repeat homozygotes versus 9-repeat carriers. For COMT, there are reports on a dose-dependent effect of the met-allele on cognitive performance [19], and thus all genotypes (val/val, val/met, met/met) were considered in the primary analysis. However, as there is also evidence for a worse performance of val-homozygotes compared to met-carriers [19] and a better performance of met-homozygotes compared to val-carriers [16], additional analyses were conducted using these groupings. For 5-HTT, there is evidence for higher expression levels and higher 5-HT uptake in l-homozygotes as compared to S-carriers. S/S and S/L genotypes in turn do not show large differences [25, 70]. Thus, group comparisons were made for l-homozygotes versus S-carriers. As both the DAT and COMT polymorphisms affect dopamine levels, a possible epistatic effect in terms of a DAT × COMT interaction was analyzed by another MANOVA now considering DAT, COMT, and diagnosis as factors.
Unlike in prior publications, we did not consider age and years of education as covariates. In the subgroups built according to the genetic polymorphisms, there were no significant differences with regard to age. As to education, there is good evidence that WM more likely exerts an effect on the individual’s educational level than vice versa as WM functioning has been proven to be a strong predictor of subsequent educational success [1, 2]. To further support this assumption, we conducted a mediation analysis according to Baron and Kenny [9] performing the following linear regression analyses:
1.
Predictor: genotype; criterion: years of education
 
2.
Predictor: genotype; criterion: WM performance (putative mediator)
 
3.
Predictors: WM performance and genotype; criterion: years of education
 
Mediation can be assumed if there is a significant effect in 1 and 2, a significant effect for the putative mediator in 3, and a reduced effect for genotype (independent variable) in 3 as compared to 1.

Results

The allelic distribution of all three genes was in Hardy-Weinberg equilibrium (DAT: df = 1, χ2 = 1.73, p = 0.189; COMT: df = 1, χ2 = 0.126, p = 0.722; 5-HTT: df = 1, χ2 = 0.062, p = 0.803). Genotype groups did not differ significantly with regard to age, gender, and diagnosis frequencies (see Table 2). As to years of education, there was a statistically significant difference for DAT genotype and a statistical trend for 5-HTT genotype.
Table 2
Demographic variables and WM task performance in dependence of DAT, COMT, and 5-HTT genotypes
 
DAT 10/10
9-Carriers
p
COMT val/val
val/met
met/met
p
5-HTT L/L
S-carriers
p
N
58
42
 
29
47
22
 
37
62
 
Age (years)b
38.17 (11.1)
36.46 (11.6)
0.457
38.73 (10.5)
38.74 (11.9)
33.73 (10.6)
0.188
38.22 (12.0)
37.16 (10.9)
0.652
Gender (m/f)a
22/36
23/19
0.095
11/18
20/27
13/9
0.292
16/21
29/33
0.733
Education (years)b
13.45 (2.7)
14.94 (2.9)
0.01
13.38 (2.5)
14.23 (2.9)
14.57 (3.2)
0.294
14.78 (3.0)
13.62 (2.8)
0.053
Diagnosis (healthy-schizophrenia-bipolar disorder-OCD)a
9-21-14-14
11-11-8-12
0.454
6-4-9-10
9-21-7-10
4-6-6-6
0.164
9-11-7-10
11-20-15-16
0.838
WM task performance (% correct)
          
Verbal rehearsalb
88.05 (9.7)
89.78 (9.1)
0.690
89.86 (8.2)
88.37 (10.6)
87.62 (8.9)
0.728
91.48 (7.4)
87.07 (10.3)
0.056
Non-articulatory phonological maintenanceb
81.67 (8.8)
81.53 (10.3)
0.696
80.05 (8.9)
82.16 (9.9)
82.09 (9.6)
0.479
85.92 (7.8)
79.04 (9.5)
0.001
Visuospatial rehearsalb
83.43 (14.1)
89.52 (10.3)
0.049
87.71 (12.5)
83.76 (13.8)
87.39 (11.5)
0.710
87.51 (10.3)
84.95 (14.4)
0.541
Visuospatial pattern maintenanceb
80.02 (12.4)
82.78 (13.2)
0.489
80.67 (13.2)
79.89 (12.7)
83.64 (12.5)
0.555
80.84 (11.6)
81.27 (13.6)
0.649
Given are the means (standard deviations) and frequencies, respectively, together with the p-values of the statistical tests
aPearson χ2
bANOVA (factor genotype for age and education; factors diagnosis, and genotype for WM performance)
According to our hypothesis that WM performance would impact on the participants’ educational level rather than vice versa, a mediation analysis according to Baron and Kenny [9] was conducted to confirm the expected mediating effect of WM performance on the dependent variable ‘years of education’. According to this approach, a series of linear regression analyses revealed:
1.
A significant effect of genotype on years of education (DAT: p = 0.01; 5-HTT: p = 0.053)
 
2.
Significant effects of DAT on visuospatial WM performance (visuospatial rehearsal: p = 0.02) and of 5-HTT on verbal WM performance (verbal rehearsal: p = 0.024)
 
3.
Significant effects of verbal (verbal rehearsal: p < 0.0005) and visuospatial WM performance (visuospatial rehearsal: p = 0.006) on years of education when controlling for genotype; a reduced significance of the effect of genotype on years of education (DAT: p = 0.044; 5-HTT: p = 0.217) when controlling for the respective WM task
 
Thus, a mediating effect of WM performance on years of education can be assumed. Consequently, years of education was not used as a covariate in the further analyses.
According to our a priori hypotheses, we then conducted analyses of variance (factors: diagnosis and genetic polymorphism) to determine the effects of the above-described DAT and COMT polymorphisms on visuospatial WM performance and of the 5-HTT polymorphism on verbal WM performance. In the following, the results are presented for each gene separately (cf. Table 2).
DAT: There was a significant effect of DAT genotype on ‘visuospatial rehearsal’ (F (1, 92) = 3.97, p = 0.049) with 10-repeat homozygote subjects showing a worse performance compared to the 9-repeat carriers. No significant effect was observed regarding ‘visuospatial pattern maintenance’.
As for diagnosis, there was a significant effect for both visuospatial WM tasks (visuospatial rehearsal: F (3, 92) = 5.3, p = 0.002; visuospatial pattern maintenance: F (3, 92) = 6.08, p = 0.001). Bonferroni-corrected pairwise comparisons revealed a significantly worse performance of the schizophrenia group when compared to the healthy subjects for both visuospatial WM tasks. There was no significant DAT-diagnosis interaction effect.
COMT: No significant effects of COMT genotype (val/val vs. val/met vs. met/met) on visuospatial WM performance were observed. Also when using other contrasts (i.e., val-homozygotes vs. met-homozygotes, val-carriers vs. met-homozygotes, and met-carriers vs. val-homozygotes), there was no significant effect of COMT genotype.
A significant effect of diagnosis was observed for both visuospatial WM tasks (visuospatial rehearsal: F (3, 86) = 3.23, p = 0.026; visuospatial pattern maintenance: F (3, 86) = 3.46, p = 0.02) with the schizophrenia group performing worse than healthy subjects in both tasks. There was no significant COMT-diagnosis interaction effect.
5-HTT: There was a significant effect of 5-HTT genotype on ‘non-articulatory phonological maintenance’ (F (1, 91) = 3.74, p = 0.001) and a statistical trend for the ‘verbal rehearsal’ task (F (1, 91) = 12.13, p = 0.056). l-homozygote subjects performed better compared to the S-allele carriers in both tasks.
A significant effect of diagnosis was present for both verbal WM tasks (non-articulatory phonological maintenance: F (3, 91) = 3.11, p = 0.03; verbal rehearsal: F (3, 91) = 7.84, p < 0.0005) with the schizophrenia group performing worse than healthy subjects in both tasks and worse than the OCD group in the verbal rehearsal task. There was no significant 5-HTT-diagnosis interaction effect.
To further test the selectivity of genotype effects as revealed by these hypothesis-driven analyses, we then conducted multivariate analyses of variance (MANOVAs; factors genotype and diagnosis) for each gene now including all applied WM tasks. In the following, we report the results of these additional multivariate analyses. The p-values of the post hoc multiple comparisons were Bonferroni-adjusted. For DAT, there was a significant main effect of diagnosis (p = 0.001) but not of DAT genotype and DAT-diagnosis interaction. In the univariate tests, there were no significant effects of DAT genotype on verbal WM performance. For COMT, there was a significant main effect of diagnosis (p = 0.003) but not of COMT genotype and COMT-diagnosis interaction. In the univariate tests, there was no significant effect of COMT genotype on verbal WM performance. For 5-HTT, there were significant effects of diagnosis (p = 0.001) and 5-HTT genotype (p = 0.005) but not of 5-HTT-diagnosis interaction. In the univariate tests, there were no significant effects of 5-HTT genotype on visuospatial WM performance.
Regarding a possible epistasis of the DAT and COMT genes, no significant DAT-COMT interaction effect was observed.

Discussion

In this study, we investigated the impact of DAT, COMT, and 5-HTT polymorphisms on verbal and visuospatial WM functioning. Our main findings are a significant and selective influence of the DAT VNTR on a visuospatial WM maintenance task and a significant and selective influence of the 5-HTTLPR on verbal WM functioning. In contrast, no significant effect on WM performance was found for the COMT Val158Met. This finding of a differential influence of functional genetic polymorphisms of the dopaminergic and serotonergic system on verbal versus visuospatial WM subcomponents gives support to our primary hypothesis that these WM functions do not only rely on distinct neuroanatomical networks but are also subject to differential genetic and neurotransmitter modulation.

Effects of DAT on working memory

Most prior studies investigating the impact of the DAT polymorphism on WM-related measures failed to find significant effects. Negative results have been reported for verbal fluency [55], WM n-back tasks [11, 12, 17], and WCST [17, 64]. In contrast, a significantly better performance of healthy DAT 10-repeat homozygotes as compared to 9-repeat carriers (and vice versa for schizophrenia patients) was found for smooth pursuit eye movement (SPEM) [69]. SPEM is a construct similar to visuospatial WM, and fMRI studies revealed overlapping brain activations during the performance of SPEM and the specific visuospatial WM task used here [10, 33]. Thus, the finding of DAT genotype affecting the performance in both tasks could reflect this functional and anatomical overlap. Further evidence for an effect of DAT genotype on spatial WM comes from an animal study, which reported Y Maze Spontaneous Alternation, a measure of spatial WM in rodents, to be impaired in DAT knockout mice as compared to the wild type [48]. The findings of the present study and the earlier literature outlined above thus support our hypothesis of an influence of DAT genotype (and thus dopamine) particularly on the visuospatial WM domain. However, interpretation of these data is restricted by different directions of the DAT effect. While we found a better visuospatial WM performance in 9-repeat carriers as compared to 10-repeat homozygotes in our mixed sample, Wonodi [69] reported the opposite effect with a better performance of the healthy 10-homozygotes. These conflicting results may be also due to the divergent findings regarding the effects of the DAT polymorphism on protein expression and consequent effects on baseline dopamine levels. While some authors reported higher DAT binding in 9-repeat carriers, others found the opposite (for review, see [68]). The effects of DAT genotype on cognition are hard to interpret as long as the functional effects of this polymorphism are not sufficiently understood. Although there is limited but consistent evidence for an influence of the DAT polymorphism on visuospatial WM and related brain functions, possible mechanisms at the level of dopaminergic neurotransmission remain to be elucidated.

Effects of COMT on working memory

Although a recent meta-analysis [7] did not find any significant effects of the COMT Val158Met-encoding polymorphism on various cognitive measures, some previous studies found such effects on n-back tasks and WCST [19, 22]. In our current study, we did not observe a significant effect of COMT genotype on either verbal or visuospatial WM maintenance tasks. A possible explanation for this divergence is the type of task used in the different studies as the construct of WM comprises a variety of test paradigms that considerably differ with respect to their cognitive demands (maintenance, manipulation, or the additional requirement of executive functions). Thus, the different WM tasks may represent at least in part different neurocognitive functions. Consistent with this, Bruder [16] investigated the effect of COMT genotype on various WM measures in healthy adults and found genotype differences only for the WCST and the letter number sequencing test (LNS) but not for a spatial delayed response task, n-back task, and word serial position test. The authors argued that COMT could selectively affect the higher-order processing components (like executive functions and mental manipulation) but not mere maintenance and updating processes. This would be in line with the negative finding for COMT in our study as we also applied rather simple WM maintenance tasks.

Differential effects of DAT and COMT on working memory

The finding of a significant influence of the DAT but not the COMT polymorphism on visuospatial WM is to some extent counterintuitive. It is widely accepted that WM functioning is particularly related to the prefrontal cortex (PFC) (e.g., [23]). Given the relative minor role of DAT for dopamine clearance in this area as compared to striatum [60, 61, 67], one would rather expect the COMT genotype to impact on WM functioning. However, the neural networks activated during WM task performance are not restricted to the PFC but involve other brain areas in which the relative importance of DAT may be different from PFC. (As Patricia Goldman-Rakic said, ‘understanding the prefrontal component is but one part of the grand design’ [23]). For the specific visuospatial WM task used here, functional activations have been shown in a bilateral prefrontoparietal network including, for instance, the cortices along posterior parts of the superior frontal sulcus and along the intraparietal sulcus [33]. Interestingly, there is evidence for the presence of DAT also apart from brain regions with established dopaminergic pathways. Lewis [47] found that DAT-immunoreactive axons are present throughout the cortex in macaques with a particularly high density of DAT immunoreactivity found in the posterior parietal cortex, suggesting a direct dopaminergic influence in this area. For humans, there is at least indirect evidence for an influence of DAT in the (posterior) parietal cortex. Two recent fMRI studies found that differences in both DAT availability [65] and DAT genotype [63] impact on brain activations in parietal regions. Thus, there is evidence for a relevant influence of DAT (be it of direct or indirect nature) on the human parietal cortex, which is activated during visuospatial WM task performance. This provides a possible explanation for our finding of a significant influence of the DAT genotype on visuospatial WM functioning.

Effects of 5-HTT on working memory

To our knowledge, this is the first report of a significant effect of the 5-HTTLPR genotype on specific verbal WM functions. Studies of an association of 5-HTTLPR with performance in the WCST yielded conflicting results with sometimes the S-allele [13] and sometimes l-homozygosity [14] being associated with better executive performance. Other recently published studies did not detect any associations between the 5-HTT polymorphism and WM measures, specifically the Count Span task [8] and a WM summary score comprising a visuospatial WM task and LNS [45].
Our finding of a better performance of l-homozygote individuals in specific verbal WM tasks thus seems to be inconsistent with these prior results. This inconsistency may, however, be explained by the type of WM measure used in the different studies. While we applied simple WM maintenance tasks, the above-mentioned studies used more complex paradigms (including more than only WM demands) or composite scores (comprising different task demands and WM domains). However, the more complex the paradigm and the more cognitive processes are involved, the more likely various neurotransmitter systems will play a role in task performance. A lack of process specificity of the applied tasks will thus dilute existing genetic effects and lead to a decreased sensitivity for their detection. Future studies should therefore apply cognitive processes that are deconstructed as far as possible to the level of ‘cognitive atoms’ as the use of such simple and purer cognitive processes seems to be a more promising approach for the investigation of genetic effects on cognition.

Limitations

The findings of our study are of course limited by the relatively small sample size and the heterogeneity of the study sample that comprised healthy subjects as well as patients with schizophrenia, bipolar I disorder, and obsessive-compulsive disorder. Replication is needed using larger and more homogeneous samples. This will also help to control for putative effects of psychopharmacological treatment on WM performance which we cannot exclude in our mixed and medicated patient sample. Publications on this issue, however, yielded contradictory results concerning whether and how antipsychotics [52, 56] and antidepressants [40, 57, 66] affect WM functioning with some evidence that putative effects depend more on individual differences in the receptor profiles of the substances (e.g., anticholinergic properties) than on mere substance class or dose effects [51, 53]. To solve the issue of possible medication effects in patient samples, studies including drug-naïve patients or prespecified pharmacological regimens are needed.
A further limitation is the use of the biallelic 5-HTTLPR polymorphism that only considered the S- and L-allele. More recent data suggest this polymorphism to be triallelic, and only the LA-allele was associated with increased 5-HTT mRNA levels in contrast to the LG-allele, which was functionally similar to the S-allele [42]. However, other recently published studies also used the biallelic 5-HTT polymorphism and reported significant effects on both cognitive measures [13, 14] and 5-HTT mRNA levels and activity [70]. Furthermore, a recent SPECT study investigating the effects of the 5-HTTLPR polymorphism on resting state perfusion in acutely depressed subjects revealed very similar findings comparing the biallelic and triallelic approach [15], which suggests that the consequences of analyzing the triallelic instead of the biallelic polymorphism might be small.

Conclusions

Summarized, our study provides evidence for an indeed differential influence of genetic polymorphisms of the serotonergic and dopaminergic system on the verbal and visuospatial subcomponent of WM. Together with prior evidence suggesting the existence of subgroups of schizophrenia patients with isolated deficits in only one working memory domain, this finding further supports the idea of endophenotypically and pathophysiologically distinct subgroups of schizophrenia with implications for possible differential and personalized therapeutic approaches. Methodologically, the use of preferably simple and pure cognitive processes seems to be a promising approach for the investigation of genetic associations with cognitive parameters and is recommended for future studies.

Conflict of interest

None.

Open Access

This article is distributed under the terms of the Creative Commons Attribution License which permits any use, distribution, and reproduction in any medium, provided the original author(s) and the source are credited.
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 2.0 International License (https://​creativecommons.​org/​licenses/​by/​2.​0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Unsere Produktempfehlungen

e.Med Interdisziplinär

Kombi-Abonnement

Für Ihren Erfolg in Klinik und Praxis - Die beste Hilfe in Ihrem Arbeitsalltag

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf SpringerMedizin.de.

Neuer Inhalt

e.Med Neurologie & Psychiatrie

Kombi-Abonnement

Mit e.Med Neurologie & Psychiatrie erhalten Sie Zugang zu CME-Fortbildungen der Fachgebiete, den Premium-Inhalten der dazugehörigen Fachzeitschriften, inklusive einer gedruckten Zeitschrift Ihrer Wahl.

Weitere Produktempfehlungen anzeigen
Literatur
1.
Zurück zum Zitat Alloway TP (2009) Working memory, but not IQ, predicts subsequent learning in children with learning difficulties. Eur J Psychol Assess 25:92–98CrossRef Alloway TP (2009) Working memory, but not IQ, predicts subsequent learning in children with learning difficulties. Eur J Psychol Assess 25:92–98CrossRef
2.
Zurück zum Zitat Alloway TP, Alloway RG (2010) Investigating the predictive roles of working memory and IQ in academic attainment. J Exp Child Psychol 106:20–29PubMedCrossRef Alloway TP, Alloway RG (2010) Investigating the predictive roles of working memory and IQ in academic attainment. J Exp Child Psychol 106:20–29PubMedCrossRef
3.
Zurück zum Zitat Awh E, Jonides J, Reuter-Lorenz PA (1998) Rehearsal in spatial working memory. J Exp Psychol Human Percept Perform 24:780–790CrossRef Awh E, Jonides J, Reuter-Lorenz PA (1998) Rehearsal in spatial working memory. J Exp Psychol Human Percept Perform 24:780–790CrossRef
4.
Zurück zum Zitat Baddeley AD (1986) Working memory. Oxford University Press, Oxford, UK Baddeley AD (1986) Working memory. Oxford University Press, Oxford, UK
5.
Zurück zum Zitat Baddeley A (2003) Working memory: looking back and looking forward. Nat Rev Neurosci 4:829–839PubMedCrossRef Baddeley A (2003) Working memory: looking back and looking forward. Nat Rev Neurosci 4:829–839PubMedCrossRef
6.
Zurück zum Zitat Barch DM (2004) Pharmacological manipulation of human working memory. Psychopharmacology 174:126–135PubMedCrossRef Barch DM (2004) Pharmacological manipulation of human working memory. Psychopharmacology 174:126–135PubMedCrossRef
7.
Zurück zum Zitat Barnett JH, Scoriels L, Munafo MR (2008) Meta-analysis of the cognitive effects of the catechol-o-methyltransferase gene val158/108met polymorphism. Biol Psychiatry 64:137–144PubMedCrossRef Barnett JH, Scoriels L, Munafo MR (2008) Meta-analysis of the cognitive effects of the catechol-o-methyltransferase gene val158/108met polymorphism. Biol Psychiatry 64:137–144PubMedCrossRef
8.
Zurück zum Zitat Barnett JH, Xu K, Heron J, Goldman D, Jones PB (2011) Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR. Am J Medical Genet B Neuropsychiatr Genet 156B:158–167CrossRef Barnett JH, Xu K, Heron J, Goldman D, Jones PB (2011) Cognitive effects of genetic variation in monoamine neurotransmitter systems: a population-based study of COMT, MAOA, and 5HTTLPR. Am J Medical Genet B Neuropsychiatr Genet 156B:158–167CrossRef
9.
Zurück zum Zitat Baron RM, Kenny DA (1986) The moderator mediator variable distinction in social psychological-research—conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182PubMedCrossRef Baron RM, Kenny DA (1986) The moderator mediator variable distinction in social psychological-research—conceptual, strategic, and statistical considerations. J Pers Soc Psychol 51:1173–1182PubMedCrossRef
10.
Zurück zum Zitat Berman RA, Colby CL, Genovese CR, Voyvodic JT, Luna B, Thulborn KR, Sweeney JA (1999) Cortical networks subserving pursuit and saccadic eye movements in humans: an fMRI study. Hum Brain Mapp 8:209–225PubMedCrossRef Berman RA, Colby CL, Genovese CR, Voyvodic JT, Luna B, Thulborn KR, Sweeney JA (1999) Cortical networks subserving pursuit and saccadic eye movements in humans: an fMRI study. Hum Brain Mapp 8:209–225PubMedCrossRef
11.
Zurück zum Zitat Bertolino A, Fazio L, Di Giorgio A, Blasi G, Romano R, Taurisano P, Caforio G, Sinibaldi L, Ursini G, Popolizio T, Tirotta E, Papp A, Dallapiccola B, Borrelli E, Sadee W (2009) Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci 29:1224–1234PubMedCrossRef Bertolino A, Fazio L, Di Giorgio A, Blasi G, Romano R, Taurisano P, Caforio G, Sinibaldi L, Ursini G, Popolizio T, Tirotta E, Papp A, Dallapiccola B, Borrelli E, Sadee W (2009) Genetically determined interaction between the dopamine transporter and the D2 receptor on prefronto-striatal activity and volume in humans. J Neurosci 29:1224–1234PubMedCrossRef
12.
Zurück zum Zitat Blanchard MM, Chamberlain SR, Roiser J, Robbins TW, Muller U (2011) Effects of two dopamine-modulating genes (DAT1 9/10 and COMT val/met) on n-back working memory performance in healthy volunteers. Psychol Med 41:611–618PubMedCrossRef Blanchard MM, Chamberlain SR, Roiser J, Robbins TW, Muller U (2011) Effects of two dopamine-modulating genes (DAT1 9/10 and COMT val/met) on n-back working memory performance in healthy volunteers. Psychol Med 41:611–618PubMedCrossRef
13.
Zurück zum Zitat Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L, Lundberg J, Jovanovic H, Andree B, Nordstrom AL, Halldin C, Eriksson E, Farde L (2009) Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int J Neuropsychopharmacol 12:783–792PubMedCrossRef Borg J, Henningsson S, Saijo T, Inoue M, Bah J, Westberg L, Lundberg J, Jovanovic H, Andree B, Nordstrom AL, Halldin C, Eriksson E, Farde L (2009) Serotonin transporter genotype is associated with cognitive performance but not regional 5-HT1A receptor binding in humans. Int J Neuropsychopharmacol 12:783–792PubMedCrossRef
14.
Zurück zum Zitat Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R (2010) HTTLPR functional polymorphism in schizophrenia: Executive functions vs. Sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry 34:81–85PubMedCrossRef Bosia M, Anselmetti S, Pirovano A, Ermoli E, Marino E, Bramanti P, Smeraldi E, Cavallaro R (2010) HTTLPR functional polymorphism in schizophrenia: Executive functions vs. Sustained attention dissociation. Prog Neuropsychopharmacol Biol Psychiatry 34:81–85PubMedCrossRef
15.
Zurück zum Zitat Brockmann H, Zobel A, Schuhmacher A, Daamen M, Joe A, Biermann K, Schwab SG, Biersack HJ, Maier W, Boecker H (2011) Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J Psychiatr Res 45:442–451PubMedCrossRef Brockmann H, Zobel A, Schuhmacher A, Daamen M, Joe A, Biermann K, Schwab SG, Biersack HJ, Maier W, Boecker H (2011) Influence of 5-HTTLPR polymorphism on resting state perfusion in patients with major depression. J Psychiatr Res 45:442–451PubMedCrossRef
16.
Zurück zum Zitat Bruder GE, Keilp JG, Xu HY, Shikhman M, Schori E, Gorman JM, Gilliam TC (2005) Catechol-o-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 58:901–907PubMedCrossRef Bruder GE, Keilp JG, Xu HY, Shikhman M, Schori E, Gorman JM, Gilliam TC (2005) Catechol-o-methyltransferase (COMT) genotypes and working memory: associations with differing cognitive operations. Biol Psychiatry 58:901–907PubMedCrossRef
17.
Zurück zum Zitat Caldu X, Vendrell P, Bartres-Faz D, Clemente I, Bargallo N, Jurado MA, Serra-Grabulosa JM, Junque C (2007) Impact of the COMT val(108/158) met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37:1437–1444PubMedCrossRef Caldu X, Vendrell P, Bartres-Faz D, Clemente I, Bargallo N, Jurado MA, Serra-Grabulosa JM, Junque C (2007) Impact of the COMT val(108/158) met and DAT genotypes on prefrontal function in healthy subjects. Neuroimage 37:1437–1444PubMedCrossRef
18.
Zurück zum Zitat Castner SA, Goldman-Rakic PS, Williams GV (2004) Animal models of working memory: Insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174:111–125PubMedCrossRef Castner SA, Goldman-Rakic PS, Williams GV (2004) Animal models of working memory: Insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology 174:111–125PubMedCrossRef
19.
Zurück zum Zitat Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT val(108/158) met genotype on frontal lobe function and risk for schizophrenia. Proc Nat Acad Sci USA 98:6917–6922PubMedCrossRef Egan MF, Goldberg TE, Kolachana BS, Callicott JH, Mazzanti CM, Straub RE, Goldman D, Weinberger DR (2001) Effect of COMT val(108/158) met genotype on frontal lobe function and risk for schizophrenia. Proc Nat Acad Sci USA 98:6917–6922PubMedCrossRef
20.
Zurück zum Zitat Ellis KA, Nathan PJ (2001) The pharmacology of human working memory. Int J Neuropsychopharmacol 4:299–313PubMedCrossRef Ellis KA, Nathan PJ (2001) The pharmacology of human working memory. Int J Neuropsychopharmacol 4:299–313PubMedCrossRef
21.
Zurück zum Zitat Forbes NF, Carrick LA, McIntosh AM, Lawrie SM (2009) Working memory in schizophrenia: a meta-analysis. Psychol Med 39:889–905PubMedCrossRef Forbes NF, Carrick LA, McIntosh AM, Lawrie SM (2009) Working memory in schizophrenia: a meta-analysis. Psychol Med 39:889–905PubMedCrossRef
22.
Zurück zum Zitat Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR (2003) Executive subprocesses in working memory—relationship to catechol-o-methyltransferase val158met genotype and schizophrenia. Arch Gen Psychiatry 60:889–896PubMedCrossRef Goldberg TE, Egan MF, Gscheidle T, Coppola R, Weickert T, Kolachana BS, Goldman D, Weinberger DR (2003) Executive subprocesses in working memory—relationship to catechol-o-methyltransferase val158met genotype and schizophrenia. Arch Gen Psychiatry 60:889–896PubMedCrossRef
24.
Zurück zum Zitat Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645PubMedCrossRef Gottesman II, Gould TD (2003) The endophenotype concept in psychiatry: etymology and strategic intentions. Am J Psychiatry 160:636–645PubMedCrossRef
25.
Zurück zum Zitat Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83–87PubMedCrossRef Greenberg BD, Tolliver TJ, Huang SJ, Li Q, Bengel D, Murphy DL (1999) Genetic variation in the serotonin transporter promoter region affects serotonin uptake in human blood platelets. Am J Med Genet 88:83–87PubMedCrossRef
26.
Zurück zum Zitat Gruber O (2001) Effects of domain-specific interference on brain activation associated with verbal working memory task performance. Cereb Cortex 11:1047–1055PubMedCrossRef Gruber O (2001) Effects of domain-specific interference on brain activation associated with verbal working memory task performance. Cereb Cortex 11:1047–1055PubMedCrossRef
27.
Zurück zum Zitat Gruber O, Goschke T (2004) Executive control emerging from dynamic interactions between brain systems mediating language, working memory and attentional processes. Acta Psychol 115:105–121CrossRef Gruber O, Goschke T (2004) Executive control emerging from dynamic interactions between brain systems mediating language, working memory and attentional processes. Acta Psychol 115:105–121CrossRef
28.
Zurück zum Zitat Gruber O, Gruber E, Falkai P (2006) Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. Neurosci Lett 405:24–28PubMedCrossRef Gruber O, Gruber E, Falkai P (2006) Articulatory rehearsal in verbal working memory: a possible neurocognitive endophenotype that differentiates between schizophrenia and schizoaffective disorder. Neurosci Lett 405:24–28PubMedCrossRef
29.
Zurück zum Zitat Gruber O, Gruber E, Falkai R (2005) Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders. Radiologe 45:153–160PubMedCrossRef Gruber O, Gruber E, Falkai R (2005) Neural correlates of working memory deficits in schizophrenic patients. Ways to establish neurocognitive endophenotypes of psychiatric disorders. Radiologe 45:153–160PubMedCrossRef
30.
Zurück zum Zitat Gruber O, Muller T, Falkai P (2007) Dynamic interactions between neural systems underlying different components of verbal working memory. J Neural Trans 114:1047–1050CrossRef Gruber O, Muller T, Falkai P (2007) Dynamic interactions between neural systems underlying different components of verbal working memory. J Neural Trans 114:1047–1050CrossRef
31.
Zurück zum Zitat Gruber O, Tost H, Henseler I, Schmael C, Scherk H, Ende G, Ruf M, Falkai P, Rietschel M (2010) Pathological amygdala activation during working memory performance: evidence for a pathophysiological trait marker in bipolar affective disorder. Hum Brain Mapp 31:115–125PubMed Gruber O, Tost H, Henseler I, Schmael C, Scherk H, Ende G, Ruf M, Falkai P, Rietschel M (2010) Pathological amygdala activation during working memory performance: evidence for a pathophysiological trait marker in bipolar affective disorder. Hum Brain Mapp 31:115–125PubMed
32.
Zurück zum Zitat Gruber O, von Cramon DY (2001) Domain-specific distribution of working memory processes along human prefrontal and parietal cortices: a functional magnetic resonance imaging study. Neurosci Lett 297:29–32PubMedCrossRef Gruber O, von Cramon DY (2001) Domain-specific distribution of working memory processes along human prefrontal and parietal cortices: a functional magnetic resonance imaging study. Neurosci Lett 297:29–32PubMedCrossRef
33.
Zurück zum Zitat Gruber O, von Cramon DY (2003) The functional neuroanatomy of human working memory revisited—evidence from 3-T fMRI studies using classical domain-specific interference tasks. Neuroimage 19:797–809PubMedCrossRef Gruber O, von Cramon DY (2003) The functional neuroanatomy of human working memory revisited—evidence from 3-T fMRI studies using classical domain-specific interference tasks. Neuroimage 19:797–809PubMedCrossRef
34.
Zurück zum Zitat Gruber O, Zilles D, Kennel J, Gruber E, Falkai P (2011) A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression. Eur Arch Psychiatry Clin Neurosci 261:179–184PubMedCrossRef Gruber O, Zilles D, Kennel J, Gruber E, Falkai P (2011) A systematic experimental neuropsychological investigation of the functional integrity of working memory circuits in major depression. Eur Arch Psychiatry Clin Neurosci 261:179–184PubMedCrossRef
35.
Zurück zum Zitat Harrison BJ, Olver JS, Norman TR, Burrows GD, Wesnes KA, Nathan PJ (2004) Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol 18:32–40PubMedCrossRef Harrison BJ, Olver JS, Norman TR, Burrows GD, Wesnes KA, Nathan PJ (2004) Selective effects of acute serotonin and catecholamine depletion on memory in healthy women. J Psychopharmacol 18:32–40PubMedCrossRef
36.
Zurück zum Zitat Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624PubMedCrossRef Heils A, Teufel A, Petri S, Stober G, Riederer P, Bengel D, Lesch KP (1996) Allelic variation of human serotonin transporter gene expression. J Neurochem 66:2621–2624PubMedCrossRef
37.
Zurück zum Zitat Henseler I, Falkai P, Gruber O (2009) A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia. Eur J Neurosci 30:693–702PubMedCrossRef Henseler I, Falkai P, Gruber O (2009) A systematic fMRI investigation of the brain systems subserving different working memory components in schizophrenia. Eur J Neurosci 30:693–702PubMedCrossRef
38.
Zurück zum Zitat Henseler I, Falkai P, Gruber O (2010) Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: Relation to performance and clinical symptoms. J Psychiatr Res 44:364–372PubMedCrossRef Henseler I, Falkai P, Gruber O (2010) Disturbed functional connectivity within brain networks subserving domain-specific subcomponents of working memory in schizophrenia: Relation to performance and clinical symptoms. J Psychiatr Res 44:364–372PubMedCrossRef
39.
Zurück zum Zitat Henseler I, Gruber O, Kraft S, Krick C, Reith W, Falkai P (2008) Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive-compulsive disorder: an fMRI study. J Psychiatry Neurosci 33:209–215PubMed Henseler I, Gruber O, Kraft S, Krick C, Reith W, Falkai P (2008) Compensatory hyperactivations as markers of latent working memory dysfunctions in patients with obsessive-compulsive disorder: an fMRI study. J Psychiatry Neurosci 33:209–215PubMed
40.
Zurück zum Zitat Herrera-Guzman I, Gudayol-Ferre E, Herrera-Guzman D, Guardia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE (2009) Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 43:855–863PubMedCrossRef Herrera-Guzman I, Gudayol-Ferre E, Herrera-Guzman D, Guardia-Olmos J, Hinojosa-Calvo E, Herrera-Abarca JE (2009) Effects of selective serotonin reuptake and dual serotonergic-noradrenergic reuptake treatments on memory and mental processing speed in patients with major depressive disorder. J Psychiatr Res 43:855–863PubMedCrossRef
41.
Zurück zum Zitat Hill SK, Harris MSH, Herbener ES, Pavuluri M, Sweeney JA (2008) Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr Bull 34:743–759PubMedCrossRef Hill SK, Harris MSH, Herbener ES, Pavuluri M, Sweeney JA (2008) Neurocognitive allied phenotypes for schizophrenia and bipolar disorder. Schizophr Bull 34:743–759PubMedCrossRef
42.
Zurück zum Zitat Hu XZ, Lipsky RH, Zhu GS, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826PubMedCrossRef Hu XZ, Lipsky RH, Zhu GS, Akhtar LA, Taubman J, Greenberg BD, Xu K, Arnold PD, Richter MA, Kennedy JL, Murphy DL, Goldman D (2006) Serotonin transporter promoter gain-of-function genotypes are linked to obsessive-compulsive disorder. Am J Hum Genet 78:815–826PubMedCrossRef
43.
Zurück zum Zitat Kimberg DY, Aguirre GK, Lease J, D’Esposito M (2001) Cortical effects of bromocriptine, a D2 dopamine receptor agonist, in human subjects, revealed by fmri. Hum Brain Mapp 12:246–257PubMedCrossRef Kimberg DY, Aguirre GK, Lease J, D’Esposito M (2001) Cortical effects of bromocriptine, a D2 dopamine receptor agonist, in human subjects, revealed by fmri. Hum Brain Mapp 12:246–257PubMedCrossRef
44.
Zurück zum Zitat Koelsch S, Schulze K, Sammler D, Fritz T, Muller K, Gruber O (2009) Functional architecture of verbal and tonal working memory: an fMRI study. Hum Brain Mapp 30:859–873PubMedCrossRef Koelsch S, Schulze K, Sammler D, Fritz T, Muller K, Gruber O (2009) Functional architecture of verbal and tonal working memory: an fMRI study. Hum Brain Mapp 30:859–873PubMedCrossRef
45.
Zurück zum Zitat Konneker TI, Crowley JJ, Quackenbush CR, Keefe RSE, Perkins DO, Stroup TS, Lieberman JA, van den Oord E, Sullivan PF (2010) No association of the serotonin transporter polymorphisms 5-HTTLPR and rs25531 with schizophrenia or neurocognition. Am J Med Genet B Neuropsychiatr Genet 153B:1115–1117PubMed Konneker TI, Crowley JJ, Quackenbush CR, Keefe RSE, Perkins DO, Stroup TS, Lieberman JA, van den Oord E, Sullivan PF (2010) No association of the serotonin transporter polymorphisms 5-HTTLPR and rs25531 with schizophrenia or neurocognition. Am J Med Genet B Neuropsychiatr Genet 153B:1115–1117PubMed
46.
Zurück zum Zitat Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF (1996) Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67:468–472PubMedCrossRef Lachman HM, Morrow B, Shprintzen R, Veit S, Parsia SS, Faedda G, Goldberg R, Kucherlapati R, Papolos DF (1996) Association of codon 108/158 catechol-o-methyltransferase gene polymorphism with the psychiatric manifestations of velo-cardio-facial syndrome. Am J Med Genet 67:468–472PubMedCrossRef
47.
Zurück zum Zitat Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A (2001) Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432:119–136PubMedCrossRef Lewis DA, Melchitzky DS, Sesack SR, Whitehead RE, Auh S, Sampson A (2001) Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization. J Comp Neurol 432:119–136PubMedCrossRef
48.
Zurück zum Zitat Li BJ, Arime Y, Hall FS, Uhl GR, Sora I (2010) Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol 628:104–107PubMedCrossRef Li BJ, Arime Y, Hall FS, Uhl GR, Sora I (2010) Impaired spatial working memory and decreased frontal cortex BDNF protein level in dopamine transporter knockout mice. Eur J Pharmacol 628:104–107PubMedCrossRef
49.
Zurück zum Zitat Luciana M, Burgund ED, Berman M, Hanson KL (2001) Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J Psychopharmacol 15:219–230PubMedCrossRef Luciana M, Burgund ED, Berman M, Hanson KL (2001) Effects of tryptophan loading on verbal, spatial and affective working memory functions in healthy adults. J Psychopharmacol 15:219–230PubMedCrossRef
50.
Zurück zum Zitat McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“Ecstasy”) users: relationship to cognitive performance. Psychopharmacology 200:439–450PubMedCrossRef McCann UD, Szabo Z, Vranesic M, Palermo M, Mathews WB, Ravert HT, Dannals RF, Ricaurte GA (2008) Positron emission tomographic studies of brain dopamine and serotonin transporters in abstinent (±)3,4-methylenedioxymethamphetamine (“Ecstasy”) users: relationship to cognitive performance. Psychopharmacology 200:439–450PubMedCrossRef
51.
Zurück zum Zitat McGurk SR, Carter C, Goldman R, Green MF, Marder SR, Xie HY, Schooler NR, Kane JM (2005) The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry 162:1013–1016PubMedCrossRef McGurk SR, Carter C, Goldman R, Green MF, Marder SR, Xie HY, Schooler NR, Kane JM (2005) The effects of clozapine and risperidone on spatial working memory in schizophrenia. Am J Psychiatry 162:1013–1016PubMedCrossRef
52.
Zurück zum Zitat McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R (2004) Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68:225–233PubMedCrossRef McGurk SR, Green MF, Wirshing WC, Wirshing DA, Marder SR, Mintz J, Kern R (2004) Antipsychotic and anticholinergic effects on two types of spatial memory in schizophrenia. Schizophr Res 68:225–233PubMedCrossRef
53.
Zurück zum Zitat Naudon L, Hotte M, Jay TM (2007) Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology 191:353–364PubMedCrossRef Naudon L, Hotte M, Jay TM (2007) Effects of acute and chronic antidepressant treatments on memory performance: a comparison between paroxetine and imipramine. Psychopharmacology 191:353–364PubMedCrossRef
54.
Zurück zum Zitat Palmason H, Moser D, Sigmund J, Vogler C, Hanig S, Schneider A, Seitz C, Marcus A, Meyer J, Freitag CM (2010) Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-o-methyltransferase variant. J Neural Trans 117:259–267CrossRef Palmason H, Moser D, Sigmund J, Vogler C, Hanig S, Schneider A, Seitz C, Marcus A, Meyer J, Freitag CM (2010) Attention-deficit/hyperactivity disorder phenotype is influenced by a functional catechol-o-methyltransferase variant. J Neural Trans 117:259–267CrossRef
55.
Zurück zum Zitat Prata DP, Mechelli A, Fu CHY, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray RM, Colliera DA, McGuire P (2009) Epistasis between the DAT 3′ UTR VNTR and the COMT val158met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Nat Acad Sci USA 106:13600–13605PubMedCrossRef Prata DP, Mechelli A, Fu CHY, Picchioni M, Toulopoulou T, Bramon E, Walshe M, Murray RM, Colliera DA, McGuire P (2009) Epistasis between the DAT 3′ UTR VNTR and the COMT val158met SNP on cortical function in healthy subjects and patients with schizophrenia. Proc Nat Acad Sci USA 106:13600–13605PubMedCrossRef
56.
Zurück zum Zitat Reilly JL, Harris MSH, Keshavan MS, Sweeney JA (2006) Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry 63:1189–1197PubMedCrossRef Reilly JL, Harris MSH, Keshavan MS, Sweeney JA (2006) Adverse effects of risperidone on spatial working memory in first-episode schizophrenia. Arch Gen Psychiatry 63:1189–1197PubMedCrossRef
57.
Zurück zum Zitat Rose EJ, Simonotto E, Spencer EP, Ebmeier KP (2006) The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology 185:339–347PubMedCrossRef Rose EJ, Simonotto E, Spencer EP, Ebmeier KP (2006) The effects of escitalopram on working memory and brain activity in healthy adults during performance of the n-back task. Psychopharmacology 185:339–347PubMedCrossRef
58.
Zurück zum Zitat Scherk H, Backens M, Schneider-Axmann T, Kraft S, Kemmer C, Usher J, Reith W, Falkai P, Meyer J, Gruber O (2009) Dopamine transporter genotype influences n-acetyl-aspartate in the left putamen. World J Biol Psychiatry 10:524–530PubMedCrossRef Scherk H, Backens M, Schneider-Axmann T, Kraft S, Kemmer C, Usher J, Reith W, Falkai P, Meyer J, Gruber O (2009) Dopamine transporter genotype influences n-acetyl-aspartate in the left putamen. World J Biol Psychiatry 10:524–530PubMedCrossRef
59.
Zurück zum Zitat Scherk H, Gruber O, Menzel P, Schneider-Axmann T, Kemmer C, Usher J, Reith W, Meyer J, Falkai P (2009) 5-HTTLPR genotype influences amygdala volume. Eur Arch Psychiatry Clin Neurosci 259:212–217PubMedCrossRef Scherk H, Gruber O, Menzel P, Schneider-Axmann T, Kemmer C, Usher J, Reith W, Meyer J, Falkai P (2009) 5-HTTLPR genotype influences amygdala volume. Eur Arch Psychiatry Clin Neurosci 259:212–217PubMedCrossRef
60.
Zurück zum Zitat Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1–57PubMedCrossRef Seamans JK, Yang CR (2004) The principal features and mechanisms of dopamine modulation in the prefrontal cortex. Prog Neurobiol 74:1–57PubMedCrossRef
61.
Zurück zum Zitat Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697–2708PubMed Sesack SR, Hawrylak VA, Matus C, Guido MA, Levey AI (1998) Dopamine axon varicosities in the prelimbic division of the rat prefrontal cortex exhibit sparse immunoreactivity for the dopamine transporter. J Neurosci 18:2697–2708PubMed
63.
Zurück zum Zitat Stollstorff M, Foss-Feig J, Cook EH, Stein MA, Gaillard WD, Vaidya CJ (2010) Neural response to working memory load varies by dopamine transporter genotype in children. Neuroimage 53:970–977PubMedCrossRef Stollstorff M, Foss-Feig J, Cook EH, Stein MA, Gaillard WD, Vaidya CJ (2010) Neural response to working memory load varies by dopamine transporter genotype in children. Neuroimage 53:970–977PubMedCrossRef
64.
Zurück zum Zitat Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, Janka Z (2004) Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 124B:1–5PubMedCrossRef Szekeres G, Keri S, Juhasz A, Rimanoczy A, Szendi I, Czimmer C, Janka Z (2004) Role of dopamine D3 receptor (DRD3) and dopamine transporter (DAT) polymorphism in cognitive dysfunctions and therapeutic response to atypical antipsychotics in patients with schizophrenia. Am J Med Genet B Neuropsychiatr Genet 124B:1–5PubMedCrossRef
65.
Zurück zum Zitat Tomasi D, Volkow ND, Wang R, Telang F, Wang G-J et al (2009) Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS ONE 4(6):e6102. doi:10.1371/journal.pone.0006102 Tomasi D, Volkow ND, Wang R, Telang F, Wang G-J et al (2009) Dopamine transporters in striatum correlate with deactivation in the default mode network during visuospatial attention. PLoS ONE 4(6):e6102. doi:10.​1371/​journal.​pone.​0006102
66.
Zurück zum Zitat Walsh ND, Williams SCR, Brammer MJ, Bullmore ET, Kim J, Suckling J, Mitterschiffthaler MT, Cleare AJ, Pich EM, Mehta MA, Fu CHY (2007) A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry 62:1236–1243PubMedCrossRef Walsh ND, Williams SCR, Brammer MJ, Bullmore ET, Kim J, Suckling J, Mitterschiffthaler MT, Cleare AJ, Pich EM, Mehta MA, Fu CHY (2007) A longitudinal functional magnetic resonance imaging study of verbal working memory in depression after antidepressant therapy. Biol Psychiatry 62:1236–1243PubMedCrossRef
67.
Zurück zum Zitat Wayment HK, Schenk JO, Sorg BA (2001) Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J Neurosci 21:35–44PubMed Wayment HK, Schenk JO, Sorg BA (2001) Characterization of extracellular dopamine clearance in the medial prefrontal cortex: role of monoamine uptake and monoamine oxidase inhibition. J Neurosci 21:35–44PubMed
68.
Zurück zum Zitat Willeit M, Praschak-Rieder N (2010) Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: a review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. Neuroimage 53:878–892PubMedCrossRef Willeit M, Praschak-Rieder N (2010) Imaging the effects of genetic polymorphisms on radioligand binding in the living human brain: a review on genetic neuroreceptor imaging of monoaminergic systems in psychiatry. Neuroimage 53:878–892PubMedCrossRef
69.
Zurück zum Zitat Wonodi I, Hong LE, Stine OC, Mitchell BD, Elliott A, Roberts RC, Conley RR, McMahon RP, Thaker GK (2009) Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 150B:282–289PubMedCrossRef Wonodi I, Hong LE, Stine OC, Mitchell BD, Elliott A, Roberts RC, Conley RR, McMahon RP, Thaker GK (2009) Dopamine transporter polymorphism modulates oculomotor function and DAT1 mRNA expression in schizophrenia. Am J Med Genet B Neuropsychiatr Genet 150B:282–289PubMedCrossRef
70.
Zurück zum Zitat Zhang HP, Smith GN, Liu XD, Holden JJA (2010) Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas. Physiol Genomics 42:85–92PubMedCrossRef Zhang HP, Smith GN, Liu XD, Holden JJA (2010) Association of MAOA, 5-HTT, and NET promoter polymorphisms with gene expression and protein activity in human placentas. Physiol Genomics 42:85–92PubMedCrossRef
71.
Zurück zum Zitat Zilles D, Burke S, Schneider-Axmann T, Falkai P, Gruber O (2009) Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:309–315PubMedCrossRef Zilles D, Burke S, Schneider-Axmann T, Falkai P, Gruber O (2009) Diagnosis-specific effect of familial loading on verbal working memory in schizophrenia. Eur Arch Psychiatry Clin Neurosci 259:309–315PubMedCrossRef
72.
Zurück zum Zitat Zilles D, Gruber E, Falkai P, Gruber O (2010) Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks. Eur Arch Psychiatry Clin Neurosci 260:519–525PubMedCrossRef Zilles D, Gruber E, Falkai P, Gruber O (2010) Patients with schizophrenia show deficits of working memory maintenance components in circuit-specific tasks. Eur Arch Psychiatry Clin Neurosci 260:519–525PubMedCrossRef
73.
Zurück zum Zitat Zilles D, Jung R, Gruber E, Falkai P, Gruber O (2011) Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks. World J Biol Psychiatry. doi:10.3109/15622975.2011.591825 PubMed Zilles D, Jung R, Gruber E, Falkai P, Gruber O (2011) Differential working memory performance as support for the Kraepelinian dichotomy between schizophrenia and bipolar disorder? An experimental neuropsychological study using circuit-specific working memory tasks. World J Biol Psychiatry. doi:10.​3109/​15622975.​2011.​591825 PubMed
Metadaten
Titel
Genetic polymorphisms of 5-HTT and DAT but not COMT differentially affect verbal and visuospatial working memory functioning
verfasst von
David Zilles
Jobst Meyer
Thomas Schneider-Axmann
Savira Ekawardhani
Eva Gruber
Peter Falkai
Oliver Gruber
Publikationsdatum
01.12.2012
Verlag
Springer-Verlag
Erschienen in
European Archives of Psychiatry and Clinical Neuroscience / Ausgabe 8/2012
Print ISSN: 0940-1334
Elektronische ISSN: 1433-8491
DOI
https://doi.org/10.1007/s00406-012-0312-0

Weitere Artikel der Ausgabe 8/2012

European Archives of Psychiatry and Clinical Neuroscience 8/2012 Zur Ausgabe

Letter to the Editor

A study that shows nothing

Update Psychiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.